← Back to guidelines
Cardiology1192 papers

Autoimmune vasculitis

Last edited: 4/23/2026

Overview

Autoimmune vasculitis encompasses a spectrum of disorders characterized by inflammation of blood vessels, leading to diverse clinical manifestations depending on the size and location of the affected vessels. These conditions can involve single or multiple organ systems, including skin, kidneys, lungs, and nervous system 1237152028303340475057.

Diagnosis

  • Clinical Presentation: Variable, including skin rash, systemic symptoms, and organ-specific manifestations 137152028303340475057.
  • Histopathology: Skin biopsy essential for definitive diagnosis, particularly in cutaneous vasculitis 126193448.
  • Serological Tests: ANCA (antineutrophil cytoplasmic antibodies) testing crucial for ANCA-associated vasculitis 153033405057.
  • Imaging: MRI, CT, and other imaging modalities useful for assessing organ involvement 2224344464.
  • Differential Diagnosis: Consider overlap syndromes and other inflammatory conditions 16213655.
  • Management

  • First-Line Treatments:
  • - Corticosteroids: High-dose initial therapy, tapering as response occurs 615304050. - Immunosuppressants: Cyclophosphamide, rituximab for severe cases 1530405062.
  • Adjunctive Therapies:
  • - Plasma Exchange: For severe renal involvement or refractory cases 1540. - Targeted Therapy: Mepolizumab in specific cases 22. - Supportive Care: Management of organ-specific complications (e.g., dialysis for renal failure) 154050.

    Special Populations

  • Pediatrics: IgA vasculitis common; careful monitoring for renal involvement 4744.
  • Elderly: Increased risk of comorbidities; tailored immunosuppressive strategies 1440.
  • Comorbidities: Consider interactions with existing conditions like cardiovascular disease 77.
  • Key Recommendations

  • Skin Biopsy for Diagnosis: Essential for confirming cutaneous vasculitis 1234. (Evidence: Strong)
  • ANCA Testing: Critical for diagnosing ANCA-associated vasculitis 15304050. (Evidence: Strong)
  • Initial High-Dose Corticosteroids: Recommended for severe vasculitis presentations 615304050. (Evidence: Moderate)
  • Cyclophosphamide for Severe Cases: Effective in severe organ involvement 154050. (Evidence: Moderate)
  • Monitor for Relapse: Use relapse scores like the French Vasculitis Study Group score for risk stratification 9. (Evidence: Moderate)
  • References

    Showing 100 most recent of 1005 indexed papers.

    1 Muñoz-Delgado DY, Barahona-Correa JE, Meléndrez-Vásquez D, Cuellar-Ríos IC, Rondón-Sepúlveda MA, Fernández-Ávila DG et al.. Evaluation of the concordance between clinical diagnosis and biopsy in cutaneous vasculitis. European journal of internal medicine 2026. link 2 Gehlhausen JR, Luyten ST, Deng J, Micevic G, Cohen JM, Damsky W et al.. Leveraging Interpretable AI for Deciphering Signature Histopathologic Patterns. Journal of cutaneous pathology 2026. link 3 Yu E, Osei-Tutu A, Subramony R. Small Vessel Vasculitis from Mycoplasma Infection and Concurrent Topical Nonsteroidal Anti-Inflammatory Drug (NSAID) Medication. The Journal of emergency medicine 2026. link 4 Fremont D, Dhaliwal S, Canney M, Akbari A, Hundemer GL, Derebail VK et al.. Hydralazine Use and Risk of Vasculitis. JAMA network open 2026. link 5 Wang GN, Wang Z, Huo H, Xu L. Machine learning differentiation of abdominal IgA vasculitis without purpura from appendicitis. Pediatric research 2026. link 6 Zhang Y, Wang Y, Zhao Z, Du H, Zong Y, Cao Y. Integrative Chinese-western therapy for Leukocytoclastic vasculitis-induced refractory leg ulcer: An 8-month healing journey with reduced corticosteroid dependency. Explore (New York, N.Y.) 2026. link 7 Cao D, Liu X. Analysis of Clinical Features and High-Risk Factors of Gastrointestinal Involvement in Children With IgA Vasculitis. Clinical pediatrics 2026. link 8 Rivero-Otamendi E, Navarro-Sánchez V, Hernández-Andrade A, Zavala-Miranda MF, Hinojosa-Azaola A, Sánchez-Mejía DE et al.. Mortality Prediction in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Kidney Involvement: Validation of the DANGER Score. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2026. link 9 Sandino-Bermúdez MJ, Mulia-Soto AS, Mejía-Vilet JM, Martín-Nares E, Hernández-López A, Hinojosa-Azaola A. Factors Associated With Relapses and Performance of the French Vasculitis Study Group Relapse Score in a Cohort of Mexican Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2026. link 10 Takano K, Hida K, Tani T, Yoshimitsu K. Vasculitis syndromes: large vessel vasculitides and ANCA-associated vasculitides from a neuroradiologist's perspective. Japanese journal of radiology 2026. link 11 Turna ZH. Vasculitis associated with nonhematological malignancies. Current opinion in rheumatology 2026. link 12 Scaglione V, Cola M, Sasset L, Fortarezza F, Casarin C, Trevenzoli M et al.. Leukocytoclastic Vasculitis Induced by Dalbavancin: A Case Report. The American journal of case reports 2026. link 13 Xie J, Shi L, Wang L, Dai J. Commentary: Anti-endothelial cell antibodies in pathogenesis of vasculitis. Frontiers in immunology 2026. link 14 Tou LC, Doyle C, Payne G, Buntyn R, Lamb J. Microscopic Polyangiitis in a Nonagenarian: Diagnostic and Therapeutic Challenges in Geriatric Vasculitis. Annals of geriatric medicine and research 2026. link 15 Mandel DA, Shekhar N, Hanna R, Reddy U. Update on antineutrophil cytoplasmic antibody vasculitis. Current opinion in nephrology and hypertension 2026. link 16 Pallotti F, Mettler C, Papo M, Iudici M, Padoan R, Sorin B et al.. Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter study. Journal of internal medicine 2026. link 17 Gulati SK, Hung W, Voaklander D, Jones CA, Yacyshyn EA. Comparing incidence of vasculitis between farming, rural and urban population: A population-based study. Clinical rheumatology 2026. link 18 Alba MA, Jennette JC. New insights into clinical spectrum of antineutrophil cytoplasmic autoantibody associated disease. Current opinion in nephrology and hypertension 2026. link 19 Wei Q, Jiang W, Chen X, Cai H, Feng R, Dong S. Leukocytoclastic Vasculitis and Profound Cytopenias Following Teicoplanin Therapy: A Case Report on Glycopeptide Cross-Reactivity. Clinical therapeutics 2026. link 20 Scoglio M, Orlando C, Milani GP, Bianchetti MG, Bronz G, Rizzi M et al.. Vasculopathy and vasculitis associated with levamisole-adulterated cocaine: a systematic review. Journal of autoimmunity 2026. link 21 Shi X, Li Z, Ma X, Zhang B, Wu X, Fan H et al.. Exploring the Vasculitis-Tumors Link: Epidemiological Patterns, Mechanistic Insights, and Clinical Implications. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026. link 22 Yamane T, Inoue A, Ichikawa C. Glucocorticoid-free remission with simultaneous mepolizumab and rituximab in life-threatening PR3-ANCA-positive eosinophilic granulomatosis with polyangiitis: a case report and literature review. Clinical rheumatology 2026. link 23 Engelstein DK, Levartovsky D, Wexler ID, Elkan PN, Padeh S, Bieber A et al.. The Natural History of Deficiency of Adenosine Deaminase 2 Vasculitis in a Large Cohort and Factors Associated With Disease-Related Damage. The Journal of rheumatology 2026. link 24 Bayindir Y, Jelusic M, Ozen S. Highlights from the breakout session: vasculitis in paediatric rheumatology. Rheumatology (Oxford, England) 2025. link 25 Kumar S, Narayanan S, Panda PK, Chowdhury A. Possible Terbinafine and/or Itraconazole Induced Vasculitis - A Case Study. Current drug safety 2025. link 26 Hansen-Abeck I, Rünger A, Piepke L, Kött J, Giordano-Rosenbaum A, Menz A et al.. Characterization of non-IgA vasculitis: Demographic, clinical, and treatment-related features in a retrospective analysis of 28 biopsy-confirmed cases from a German university hospital. The Journal of dermatology 2025. link 27 Saro-Buendía M, Mansilla-Polo M, García-Piñero A, Armengot-Carceller M. Stimulator of interferon genes-associated vasculopathy with onset in infancy (SAVI syndrome). European annals of otorhinolaryngology, head and neck diseases 2025. link 28 Pacut P, Gwathmey KG. Top 10 Clinical Pearls in Vasculitic Neuropathies. Seminars in neurology 2025. link 29 Katsumata Y, Sada KE, Kameda T, Dobashi H, Kaname S, Tsuboi N et al.. Comparison of different ANCA detection methods in a predominantly MPO-ANCA-associated vasculitis cohort. Immunological medicine 2025. link 30 Maeda Y, Ikeguchi R, Masui K, Kurata A, Kitagawa K, Shimizu Y. Anti-neutrophil cytoplasmic antibody-associated central nervous system vasculitis mimicking brain tumor: A case report. Neuropathology : official journal of the Japanese Society of Neuropathology 2025. link 31 Benson D. Imaging of Pulmonary Vasculitis. Radiologic clinics of North America 2025. link 32 Gagne SJ, Sivaraman V, Bosman ES, Klamer B, Morishita KA, Huber A et al.. Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood-Onset Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An ARChiVe Registry Cohort Study. Arthritis care & research 2025. link 33 McLean-Tooke A, Ong J, Kwan A, Krummenacher M, Bundell C. Diagnostic performance of assays for urgent MPO, PR3 and GBM autoantibodies in suspected vasculitis. Pathology 2025. link 34 Fukami S, Ohmura SI, Masui T, Otsuki Y, Yukishima T, Yonezawa H et al.. MRI-guided muscle biopsy improves diagnostic yield in small- to medium-vessel vasculitis: a retrospective single-center study. Rheumatology international 2025. link 35 Ruffer N, Pinal-Fernandez I, Preusse C, Mammen AL, Holzer MT, Kleefeld F et al.. Vasculitic fasciitis characterizes a distinct subset of vasculitic myopathy with interferon-gamma signature. Acta neuropathologica 2025. link 36 Zedde M, Quatrale R, Andreone V, Pezzella FR, Micieli G, Cortelli P et al.. Post-infectious central nervous system vasculitides in adults: an underdiagnosed and treatable disease part II. Neuroimaging of selected etiologies : Part II. Neuroimaging of selected etiologies. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025. link 37 Hendrickson MJ, Wallace ZS. Mechanisms and Screening for Atherosclerosis in Adults With Vasculitis. Arteriosclerosis, thrombosis, and vascular biology 2025. link 38 Fernandez-Flores A. Concepts in Cutaneous Vasculitis. The American Journal of dermatopathology 2025. link 39 Watanabe K, Shimada N, Kanzaki M, Fukuoka K, Asano K. Late-onset Neutropenia after Rituximab Treatment for MPO-ANCA-associated Vasculitis. Internal medicine (Tokyo, Japan) 2025. link 40 Imai Y, Ota Y, Matsumoto K, Akiyama M, Suzuki K, Kaneko Y. Performance of the 2022 ACR/EULAR Classification Criteria in Comparison With the European Medicines Agency Algorithm in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. The Journal of rheumatology 2024. link 41 Renuncio-García M, Calvo-Río V, Benavides-Villanueva F, Al Fazazi S, Rodríguez-Vidriales M, Escagedo-Cagigas C et al.. ANCA detection with solid phase chemiluminescence assay: diagnostic and severity association in vasculitis. Immunologic research 2024. link 42 Padilha IG, Nehme A, de Boysson H, Létourneau-Guillon L. Imaging of Vasculitis Associated with Systemic Disease. Neuroimaging clinics of North America 2024. link 43 Hamam O, Cartmell SC, Romero JM. Imaging of Small Artery Vasculitis. Neuroimaging clinics of North America 2024. link 44 Ahn SS, Heo SJ, Ha JW, Park YB, Lee SW. Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort. Seminars in arthritis and rheumatism 2024. link 45 Pochepnia S, Lang IM, Milos RI, Röhrich S, Ba-Ssalamah A, Beer L et al.. Hughes-Stovin syndrome-An important differential diagnosis in patients with suspected chronic thromboembolic pulmonary hypertension : A case report. Wiener klinische Wochenschrift 2024. link 46 Fadoul MA, Tjaden B, Daneshpooy S, McMackin K. Spontaneous brachial artery pseudoaneurysm secondary to vasculitis. Vascular 2024. link 47 Yang K, Tang J, Li H, Zhang H, Ding J, Li Z et al.. LncRNAs in Kawasaki disease and Henoch-Schönlein purpura: mechanisms and clinical applications. Molecular and cellular biochemistry 2024. link 48 Isoherranen K, Kluger N, Hannula-Jouppi K, Väkevä L. The Role of Negative Pressure Wound Therapy (NPWT) in the Management of Vasculitic Wounds: Case Series of Eight Patients. The international journal of lower extremity wounds 2024. link 49 Coorey CP, Aarabi A, Kumar K. Mixed cryoglobulinaemia vasculitis secondary to marginal zone lymphoma in a patient with end-stage renal failure on haemodialysis. CEN case reports 2024. link 50 Nunes RH, Corrêa DG, Pacheco FT, Fonseca APA, Hygino da Cruz LC, da Rocha AJ. Neuroimaging of Infectious Vasculopathy. Neuroimaging clinics of North America 2024. link 51 Sherri A, Mortada MM, Makowska J, Lewandowska-Polak A. Primary angiitis of the CNS and ANCA-associated vasculitis: from pathology to treatment. Rheumatology international 2024. link 52 Korkmaz C, Yıldırım R, Dinler M, Cansu DU. Coexistence of IgG4-related disease and ANCA-associated vasculitis: case report and review of the literature. Rheumatology international 2024. link 53 Saha MK. Overview of Vasculitides in Adults. Neuroimaging clinics of North America 2024. link 54 Sawhney S. Childhood Vasculitis. Indian journal of pediatrics 2024. link 55 Nomura S, Shimojima Y, Ichikawa T, Miyazaki D, Uruha A, Kishida D et al.. Immunopathological features of myopathy associated with small-to-medium-sized vessel vasculitis and differences from autoimmune myositis. Clinical and experimental rheumatology 2024. link 56 Yun JD, Lee JH, Pyo JY, Ahn SS, Song JJ, Park YB et al.. Birmingham vasculitis activity score and the short form 36-item health survey predict current depressive disorders in patients with antineutrophil cytoplasmic antibody-associated vasculitis during the SARS-CoV-2 pandemic. Zeitschrift fur Rheumatologie 2024. link 57 Manfredi A, Cassone G, Izzo R, Dallagiacoma G, Felicetti M, Cariddi A et al.. Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology. Clinical and experimental rheumatology 2023. link 58 Ecclestone T, Watts RA. Classification and epidemiology of vasculitis: Emerging concepts. Best practice & research. Clinical rheumatology 2023. link 59 Yamaguchi K, Yamaguchi A, Ito M, Wakamatsu I, Itai M, Muto S et al.. Clinical differences among patients with myeloperoxidase-antineutrophil cytoplasmic antibody-positive interstitial lung disease. Clinical rheumatology 2023. link 60 Ak T, Durmus RB, Onel M. Cutaneous vasculitis associated with molecular tergeted therapies: systematic review of the literature. Clinical rheumatology 2023. link 61 Ando T, Watanabe H, Riku Y, Yoshida M, Goto Y, Ando R et al.. Neurogenic intermittent claudication caused by vasculitis in the cauda equina: an autopsy case report. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 2023. link 62 Aymonnier K, Amsler J, Lamprecht P, Salama A, Witko-Sarsat V. The neutrophil: A key resourceful agent in immune-mediated vasculitis. Immunological reviews 2023. link 63 Xiong Q, Lin W, Shen C, Meng T, Tang R, Ooi JD et al.. Coexistence of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and IgA nephropathy. Immunologic research 2023. link 64 Arnett N, Pavlou A, Burke MP, Cucchiara BL, Rhee RL, Song JW. Vessel wall MR imaging of central nervous system vasculitis: a systematic review. Neuroradiology 2022. link 65 Bazzi N, Salloum A, Chebl JA, Hreibe W, Bazzi M, Fiani E et al.. Juvenile gangrenous vasculitis of the scrotum: systematic review. International journal of dermatology 2022. link 66 Guda VA, Brown ME, Palacios M. Spontaneous ecchymoses. The Journal of family practice 2022. link 67 Carette S. Vasculitis: What Have We Learned in the Last 50 Years?. The Journal of rheumatology 2022. link 68 Pimentel-Quiroz VR, Sánchez-Torres A, Reátegui-Sokolova C, Gamboa-Cárdenas RV, Sánchez-Schwartz C, Medina-Chinchón M et al.. Performance of the 2017 American College of Rheumatology/European League Against Rheumatism Provisional Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in a Peruvian Tertiary Care Center. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2022. link 69 Quan Z, Liu M, Zhao J, Yang X. Correlation between early changes of serum lipids and clinical severity in patients with wasp stings. Journal of clinical lipidology 2022. link 70 Ball-Burack MR, Kosowsky JM. A Case of Leukocytoclastic Vasculitis Following SARS-COV-2 Vaccination. The Journal of emergency medicine 2022. link 71 Takeyama R, Fukuda K, Kouzaki Y, Koga T, Hayashi S, Ohtani H et al.. Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report. Acta neurochirurgica 2022. link 72 Altun E, Kuzucular E. Leukocytoclastic vasculitis after COVID-19 vaccination. Dermatologic therapy 2022. link 73 Yoon T, Ahn SS, Pyo JY, Song JJ, Park YB, Lee SW. Serum vitamin D level correlates with disease activity and health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis. Zeitschrift fur Rheumatologie 2022. link 74 Hecker C, Welponer T, Herold M, Trinka E, Broussalis E, Killer-Oberpfalzer M. Update on treatment strategies for vasculitis affecting the central nervous system. Drug discovery today 2022. link 75 Folci M, Ramponi G, Solitano V, Brunetta E. Serum ANCA as Disease Biomarkers: Clinical Implications Beyond Vasculitis. Clinical reviews in allergy & immunology 2022. link 76 Yanartaş M, Karakoç AZ, Zengin A, Taş S, Olgun-Yildizeli Ş, Mutlu B et al.. Multimodal Approach of Isolated Pulmonary Vasculitis: A Single-Institution Experience. The Annals of thoracic surgery 2022. link 77 Kawashima S, Kishimoto M, Hibino T, Lee H, Sato Y, Komagata Y et al.. MPO-ANCA-positive Microscopic Polyangiitis Following COVID-19 Infection. Internal medicine (Tokyo, Japan) 2022. link 78 Yang S, Chai D, Li Y, Wang Y, Zhan X, Zhang L et al.. Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculitis: a single-center retrospective study. Clinical rheumatology 2022. link 79 Meng T, Shen C, Tang R, Lin W, Ooi JD, Eggenhuizen PJ et al.. Clinical features and outcomes of anti-neutrophil cytoplasmic autoantibody-associated vasculitis in Chinese childhood-onset patients. Clinical and experimental medicine 2022. link 80 Yamamoto S, Mukai T, Fujita S, Koide Y, Ono Y, Inubushi M et al.. The "Ant-farm"-like Appearance of Restricted Lower Limb Vasculitis on Fluorodeoxyglucose-positron Emission Tomography. Internal medicine (Tokyo, Japan) 2022. link 81 Kilduff S, Butler J, Sogawa H, Solomon S. Practice patterns and outcomes for pediatric ANCA vasculitis transplant recipients in a national cohort. Pediatric nephrology (Berlin, Germany) 2022. link 82 Fiorillo G, Pancetti S, Cortese A, Toso F, Manara S, Costanzo A et al.. Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination. Journal of autoimmunity 2022. link 83 Wu Z, Gao S, Watanabe N, Batchu S, Kajigaya S, Diamond C et al.. Single-cell profiling of T lymphocytes in deficiency of adenosine deaminase 2. Journal of leukocyte biology 2022. link 84 Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G et al.. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis & rheumatology (Hoboken, N.J.) 2021. link 85 Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G et al.. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis care & research 2021. link 86 Torp CK, Brüner M, Keller KK, Brouwer E, Hauge EM, McGonagle D et al.. Vasculitis therapy refines vasculitis mechanistic classification. Autoimmunity reviews 2021. link 87 Aghayev A, Steigner ML, Azene EM, Burns J, Chareonthaitawee P, Desjardins B et al.. ACR Appropriateness Criteria® Noncerebral Vasculitis. Journal of the American College of Radiology : JACR 2021. link 88 Sneller H, Vega C, Zemel L, Chicaiza HP. Acute Hemorrhagic Edema of Infancy With Associated Hemorrhagic Lacrimation. Pediatric emergency care 2021. link 89 Krasselt M, Baerwald C, Petros S, Seifert O. Outcome of Patients With Necrotizing Vasculitis Admitted to the Intensive Care Unit (ICU) for Sepsis: Results of a Single-Centre Retrospective Analysis. Journal of intensive care medicine 2021. link 90 Weinberg M, Bag-Ozbek A, Chen D, Yao Q. Small vessel vasculitis secondary to Mycobacterium chelonae. Rheumatology international 2021. link 91 Gehlhausen JR, Wetter DA, Nelson C, Ramachandran S, McNiff JM, Ko CJ. A detailed analysis of the distribution, morphology, and histopathology of complex purpura in hospitalized patients: A case series of 68 patients. Journal of the American Academy of Dermatology 2021. link 92 Mustapha N, Barra L, Carette S, Cuthbertson D, Khalidi NA, Koening CL et al.. Efficacy of leflunomide in the treatment of vasculitis. Clinical and experimental rheumatology 2021. link 93 Pfeuffer-Jovic E, Heyckendorf J, Reischl U, Bohle RM, Bley T, Buck A et al.. Pulmonary vasculitis due to infection with Mycobacterium goodii: A case report. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2021. link 94 Mendel A, Ennis D, Carette S, Pagnoux C. Assessment of glucocorticoid tapering in large vessel and anti-neutrophil cytoplasmic antibody-associated vasculitides. Clinical and experimental rheumatology 2021. link 95 Singh JA. Infection versus cardiovascular disease as leading causes of hospitalisations and associated mortality in vasculitis in the U.S.: a national study. Clinical and experimental rheumatology 2021. link 96 Hiruma M, Sasano Y, Watanabe N, Yoshihara A, Ishii S, Yaguchi Y et al.. Propylthiouracil-induced otitis media with anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report and review of the literature. Endocrine journal 2021. link 97 Takeyama Y, Ono N, Shirahama Y, Inoue Y, Tanaka A, Ueda N et al.. Rituximab maintenance therapy for patients with antineutrophil cytoplasmic antibody-associated vasculitis in Japan. Modern rheumatology 2021. link 98 Shibata A, Kondo T, Kurasawa T, Chino K, Okada Y, Amano K. A case of polyangiitis overlap syndrome of giant cell arteritis and granulomatosis with polyangiitis successfully treated with rituximab. Modern rheumatology case reports 2021. link 99 Gill N, Tervaert JWC, Yacyshyn E. Vasculitis patient journey: a scoping review of patient experiences with vasculitis. Clinical rheumatology 2021. link 100 Russo R, Cozzani E, Murdaca G, dePasquale R, Parodi A. Spontaneous Ecchymotic Lesions with Systemic Symptoms: A Quiz. Acta dermato-venereologica 2020. link

    Original source

    1. [1]
      Evaluation of the concordance between clinical diagnosis and biopsy in cutaneous vasculitis.Muñoz-Delgado DY, Barahona-Correa JE, Meléndrez-Vásquez D, Cuellar-Ríos IC, Rondón-Sepúlveda MA, Fernández-Ávila DG et al. European journal of internal medicine (2026)
    2. [2]
      Leveraging Interpretable AI for Deciphering Signature Histopathologic Patterns.Gehlhausen JR, Luyten ST, Deng J, Micevic G, Cohen JM, Damsky W et al. Journal of cutaneous pathology (2026)
    3. [3]
    4. [4]
      Hydralazine Use and Risk of Vasculitis.Fremont D, Dhaliwal S, Canney M, Akbari A, Hundemer GL, Derebail VK et al. JAMA network open (2026)
    5. [5]
    6. [6]
    7. [7]
    8. [8]
      Mortality Prediction in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Kidney Involvement: Validation of the DANGER Score.Rivero-Otamendi E, Navarro-Sánchez V, Hernández-Andrade A, Zavala-Miranda MF, Hinojosa-Azaola A, Sánchez-Mejía DE et al. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (2026)
    9. [9]
      Factors Associated With Relapses and Performance of the French Vasculitis Study Group Relapse Score in a Cohort of Mexican Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.Sandino-Bermúdez MJ, Mulia-Soto AS, Mejía-Vilet JM, Martín-Nares E, Hernández-López A, Hinojosa-Azaola A Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (2026)
    10. [10]
      Vasculitis syndromes: large vessel vasculitides and ANCA-associated vasculitides from a neuroradiologist's perspective.Takano K, Hida K, Tani T, Yoshimitsu K Japanese journal of radiology (2026)
    11. [11]
      Vasculitis associated with nonhematological malignancies.Turna ZH Current opinion in rheumatology (2026)
    12. [12]
      Leukocytoclastic Vasculitis Induced by Dalbavancin: A Case Report.Scaglione V, Cola M, Sasset L, Fortarezza F, Casarin C, Trevenzoli M et al. The American journal of case reports (2026)
    13. [13]
      Commentary: Anti-endothelial cell antibodies in pathogenesis of vasculitis.Xie J, Shi L, Wang L, Dai J Frontiers in immunology (2026)
    14. [14]
      Microscopic Polyangiitis in a Nonagenarian: Diagnostic and Therapeutic Challenges in Geriatric Vasculitis.Tou LC, Doyle C, Payne G, Buntyn R, Lamb J Annals of geriatric medicine and research (2026)
    15. [15]
      Update on antineutrophil cytoplasmic antibody vasculitis.Mandel DA, Shekhar N, Hanna R, Reddy U Current opinion in nephrology and hypertension (2026)
    16. [16]
      Overlapping forms of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis: Insights from a European multicenter study.Pallotti F, Mettler C, Papo M, Iudici M, Padoan R, Sorin B et al. Journal of internal medicine (2026)
    17. [17]
      Comparing incidence of vasculitis between farming, rural and urban population: A population-based study.Gulati SK, Hung W, Voaklander D, Jones CA, Yacyshyn EA Clinical rheumatology (2026)
    18. [18]
      New insights into clinical spectrum of antineutrophil cytoplasmic autoantibody associated disease.Alba MA, Jennette JC Current opinion in nephrology and hypertension (2026)
    19. [19]
    20. [20]
      Vasculopathy and vasculitis associated with levamisole-adulterated cocaine: a systematic review.Scoglio M, Orlando C, Milani GP, Bianchetti MG, Bronz G, Rizzi M et al. Journal of autoimmunity (2026)
    21. [21]
      Exploring the Vasculitis-Tumors Link: Epidemiological Patterns, Mechanistic Insights, and Clinical Implications.Shi X, Li Z, Ma X, Zhang B, Wu X, Fan H et al. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2026)
    22. [22]
    23. [23]
      The Natural History of Deficiency of Adenosine Deaminase 2 Vasculitis in a Large Cohort and Factors Associated With Disease-Related Damage.Engelstein DK, Levartovsky D, Wexler ID, Elkan PN, Padeh S, Bieber A et al. The Journal of rheumatology (2026)
    24. [24]
      Highlights from the breakout session: vasculitis in paediatric rheumatology.Bayindir Y, Jelusic M, Ozen S Rheumatology (Oxford, England) (2025)
    25. [25]
      Possible Terbinafine and/or Itraconazole Induced Vasculitis - A Case Study.Kumar S, Narayanan S, Panda PK, Chowdhury A Current drug safety (2025)
    26. [26]
    27. [27]
      Stimulator of interferon genes-associated vasculopathy with onset in infancy (SAVI syndrome).Saro-Buendía M, Mansilla-Polo M, García-Piñero A, Armengot-Carceller M European annals of otorhinolaryngology, head and neck diseases (2025)
    28. [28]
      Top 10 Clinical Pearls in Vasculitic Neuropathies.Pacut P, Gwathmey KG Seminars in neurology (2025)
    29. [29]
      Comparison of different ANCA detection methods in a predominantly MPO-ANCA-associated vasculitis cohort.Katsumata Y, Sada KE, Kameda T, Dobashi H, Kaname S, Tsuboi N et al. Immunological medicine (2025)
    30. [30]
      Anti-neutrophil cytoplasmic antibody-associated central nervous system vasculitis mimicking brain tumor: A case report.Maeda Y, Ikeguchi R, Masui K, Kurata A, Kitagawa K, Shimizu Y Neuropathology : official journal of the Japanese Society of Neuropathology (2025)
    31. [31]
      Imaging of Pulmonary Vasculitis.Benson D Radiologic clinics of North America (2025)
    32. [32]
    33. [33]
      Diagnostic performance of assays for urgent MPO, PR3 and GBM autoantibodies in suspected vasculitis.McLean-Tooke A, Ong J, Kwan A, Krummenacher M, Bundell C Pathology (2025)
    34. [34]
      MRI-guided muscle biopsy improves diagnostic yield in small- to medium-vessel vasculitis: a retrospective single-center study.Fukami S, Ohmura SI, Masui T, Otsuki Y, Yukishima T, Yonezawa H et al. Rheumatology international (2025)
    35. [35]
      Vasculitic fasciitis characterizes a distinct subset of vasculitic myopathy with interferon-gamma signature.Ruffer N, Pinal-Fernandez I, Preusse C, Mammen AL, Holzer MT, Kleefeld F et al. Acta neuropathologica (2025)
    36. [36]
      Post-infectious central nervous system vasculitides in adults: an underdiagnosed and treatable disease part II. Neuroimaging of selected etiologies : Part II. Neuroimaging of selected etiologies.Zedde M, Quatrale R, Andreone V, Pezzella FR, Micieli G, Cortelli P et al. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2025)
    37. [37]
      Mechanisms and Screening for Atherosclerosis in Adults With Vasculitis.Hendrickson MJ, Wallace ZS Arteriosclerosis, thrombosis, and vascular biology (2025)
    38. [38]
      Concepts in Cutaneous Vasculitis.Fernandez-Flores A The American Journal of dermatopathology (2025)
    39. [39]
      Late-onset Neutropenia after Rituximab Treatment for MPO-ANCA-associated Vasculitis.Watanabe K, Shimada N, Kanzaki M, Fukuoka K, Asano K Internal medicine (Tokyo, Japan) (2025)
    40. [40]
    41. [41]
      ANCA detection with solid phase chemiluminescence assay: diagnostic and severity association in vasculitis.Renuncio-García M, Calvo-Río V, Benavides-Villanueva F, Al Fazazi S, Rodríguez-Vidriales M, Escagedo-Cagigas C et al. Immunologic research (2024)
    42. [42]
      Imaging of Vasculitis Associated with Systemic Disease.Padilha IG, Nehme A, de Boysson H, Létourneau-Guillon L Neuroimaging clinics of North America (2024)
    43. [43]
      Imaging of Small Artery Vasculitis.Hamam O, Cartmell SC, Romero JM Neuroimaging clinics of North America (2024)
    44. [44]
    45. [45]
      Hughes-Stovin syndrome-An important differential diagnosis in patients with suspected chronic thromboembolic pulmonary hypertension : A case report.Pochepnia S, Lang IM, Milos RI, Röhrich S, Ba-Ssalamah A, Beer L et al. Wiener klinische Wochenschrift (2024)
    46. [46]
      Spontaneous brachial artery pseudoaneurysm secondary to vasculitis.Fadoul MA, Tjaden B, Daneshpooy S, McMackin K Vascular (2024)
    47. [47]
      LncRNAs in Kawasaki disease and Henoch-Schönlein purpura: mechanisms and clinical applications.Yang K, Tang J, Li H, Zhang H, Ding J, Li Z et al. Molecular and cellular biochemistry (2024)
    48. [48]
      The Role of Negative Pressure Wound Therapy (NPWT) in the Management of Vasculitic Wounds: Case Series of Eight Patients.Isoherranen K, Kluger N, Hannula-Jouppi K, Väkevä L The international journal of lower extremity wounds (2024)
    49. [49]
    50. [50]
      Neuroimaging of Infectious Vasculopathy.Nunes RH, Corrêa DG, Pacheco FT, Fonseca APA, Hygino da Cruz LC, da Rocha AJ Neuroimaging clinics of North America (2024)
    51. [51]
      Primary angiitis of the CNS and ANCA-associated vasculitis: from pathology to treatment.Sherri A, Mortada MM, Makowska J, Lewandowska-Polak A Rheumatology international (2024)
    52. [52]
      Coexistence of IgG4-related disease and ANCA-associated vasculitis: case report and review of the literature.Korkmaz C, Yıldırım R, Dinler M, Cansu DU Rheumatology international (2024)
    53. [53]
      Overview of Vasculitides in Adults.Saha MK Neuroimaging clinics of North America (2024)
    54. [54]
      Childhood Vasculitis.Sawhney S Indian journal of pediatrics (2024)
    55. [55]
      Immunopathological features of myopathy associated with small-to-medium-sized vessel vasculitis and differences from autoimmune myositis.Nomura S, Shimojima Y, Ichikawa T, Miyazaki D, Uruha A, Kishida D et al. Clinical and experimental rheumatology (2024)
    56. [56]
    57. [57]
    58. [58]
      Classification and epidemiology of vasculitis: Emerging concepts.Ecclestone T, Watts RA Best practice & research. Clinical rheumatology (2023)
    59. [59]
      Clinical differences among patients with myeloperoxidase-antineutrophil cytoplasmic antibody-positive interstitial lung disease.Yamaguchi K, Yamaguchi A, Ito M, Wakamatsu I, Itai M, Muto S et al. Clinical rheumatology (2023)
    60. [60]
    61. [61]
      Neurogenic intermittent claudication caused by vasculitis in the cauda equina: an autopsy case report.Ando T, Watanabe H, Riku Y, Yoshida M, Goto Y, Ando R et al. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society (2023)
    62. [62]
      The neutrophil: A key resourceful agent in immune-mediated vasculitis.Aymonnier K, Amsler J, Lamprecht P, Salama A, Witko-Sarsat V Immunological reviews (2023)
    63. [63]
      Coexistence of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and IgA nephropathy.Xiong Q, Lin W, Shen C, Meng T, Tang R, Ooi JD et al. Immunologic research (2023)
    64. [64]
      Vessel wall MR imaging of central nervous system vasculitis: a systematic review.Arnett N, Pavlou A, Burke MP, Cucchiara BL, Rhee RL, Song JW Neuroradiology (2022)
    65. [65]
      Juvenile gangrenous vasculitis of the scrotum: systematic review.Bazzi N, Salloum A, Chebl JA, Hreibe W, Bazzi M, Fiani E et al. International journal of dermatology (2022)
    66. [66]
      Spontaneous ecchymoses.Guda VA, Brown ME, Palacios M The Journal of family practice (2022)
    67. [67]
      Vasculitis: What Have We Learned in the Last 50 Years?Carette S The Journal of rheumatology (2022)
    68. [68]
      Performance of the 2017 American College of Rheumatology/European League Against Rheumatism Provisional Classification Criteria for Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in a Peruvian Tertiary Care Center.Pimentel-Quiroz VR, Sánchez-Torres A, Reátegui-Sokolova C, Gamboa-Cárdenas RV, Sánchez-Schwartz C, Medina-Chinchón M et al. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (2022)
    69. [69]
      Correlation between early changes of serum lipids and clinical severity in patients with wasp stings.Quan Z, Liu M, Zhao J, Yang X Journal of clinical lipidology (2022)
    70. [70]
      A Case of Leukocytoclastic Vasculitis Following SARS-COV-2 Vaccination.Ball-Burack MR, Kosowsky JM The Journal of emergency medicine (2022)
    71. [71]
      Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: a case report.Takeyama R, Fukuda K, Kouzaki Y, Koga T, Hayashi S, Ohtani H et al. Acta neurochirurgica (2022)
    72. [72]
      Leukocytoclastic vasculitis after COVID-19 vaccination.Altun E, Kuzucular E Dermatologic therapy (2022)
    73. [73]
    74. [74]
      Update on treatment strategies for vasculitis affecting the central nervous system.Hecker C, Welponer T, Herold M, Trinka E, Broussalis E, Killer-Oberpfalzer M Drug discovery today (2022)
    75. [75]
      Serum ANCA as Disease Biomarkers: Clinical Implications Beyond Vasculitis.Folci M, Ramponi G, Solitano V, Brunetta E Clinical reviews in allergy & immunology (2022)
    76. [76]
      Multimodal Approach of Isolated Pulmonary Vasculitis: A Single-Institution Experience.Yanartaş M, Karakoç AZ, Zengin A, Taş S, Olgun-Yildizeli Ş, Mutlu B et al. The Annals of thoracic surgery (2022)
    77. [77]
      MPO-ANCA-positive Microscopic Polyangiitis Following COVID-19 Infection.Kawashima S, Kishimoto M, Hibino T, Lee H, Sato Y, Komagata Y et al. Internal medicine (Tokyo, Japan) (2022)
    78. [78]
      Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculitis: a single-center retrospective study.Yang S, Chai D, Li Y, Wang Y, Zhan X, Zhang L et al. Clinical rheumatology (2022)
    79. [79]
      Clinical features and outcomes of anti-neutrophil cytoplasmic autoantibody-associated vasculitis in Chinese childhood-onset patients.Meng T, Shen C, Tang R, Lin W, Ooi JD, Eggenhuizen PJ et al. Clinical and experimental medicine (2022)
    80. [80]
      The "Ant-farm"-like Appearance of Restricted Lower Limb Vasculitis on Fluorodeoxyglucose-positron Emission Tomography.Yamamoto S, Mukai T, Fujita S, Koide Y, Ono Y, Inubushi M et al. Internal medicine (Tokyo, Japan) (2022)
    81. [81]
      Practice patterns and outcomes for pediatric ANCA vasculitis transplant recipients in a national cohort.Kilduff S, Butler J, Sogawa H, Solomon S Pediatric nephrology (Berlin, Germany) (2022)
    82. [82]
      Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination.Fiorillo G, Pancetti S, Cortese A, Toso F, Manara S, Costanzo A et al. Journal of autoimmunity (2022)
    83. [83]
      Single-cell profiling of T lymphocytes in deficiency of adenosine deaminase 2.Wu Z, Gao S, Watanabe N, Batchu S, Kajigaya S, Diamond C et al. Journal of leukocyte biology (2022)
    84. [84]
      2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G et al. Arthritis & rheumatology (Hoboken, N.J.) (2021)
    85. [85]
      2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G et al. Arthritis care & research (2021)
    86. [86]
      Vasculitis therapy refines vasculitis mechanistic classification.Torp CK, Brüner M, Keller KK, Brouwer E, Hauge EM, McGonagle D et al. Autoimmunity reviews (2021)
    87. [87]
      ACR Appropriateness Criteria® Noncerebral Vasculitis.Aghayev A, Steigner ML, Azene EM, Burns J, Chareonthaitawee P, Desjardins B et al. Journal of the American College of Radiology : JACR (2021)
    88. [88]
      Acute Hemorrhagic Edema of Infancy With Associated Hemorrhagic Lacrimation.Sneller H, Vega C, Zemel L, Chicaiza HP Pediatric emergency care (2021)
    89. [89]
    90. [90]
      Small vessel vasculitis secondary to Mycobacterium chelonae.Weinberg M, Bag-Ozbek A, Chen D, Yao Q Rheumatology international (2021)
    91. [91]
      A detailed analysis of the distribution, morphology, and histopathology of complex purpura in hospitalized patients: A case series of 68 patients.Gehlhausen JR, Wetter DA, Nelson C, Ramachandran S, McNiff JM, Ko CJ Journal of the American Academy of Dermatology (2021)
    92. [92]
      Efficacy of leflunomide in the treatment of vasculitis.Mustapha N, Barra L, Carette S, Cuthbertson D, Khalidi NA, Koening CL et al. Clinical and experimental rheumatology (2021)
    93. [93]
      Pulmonary vasculitis due to infection with Mycobacterium goodii: A case report.Pfeuffer-Jovic E, Heyckendorf J, Reischl U, Bohle RM, Bley T, Buck A et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2021)
    94. [94]
      Assessment of glucocorticoid tapering in large vessel and anti-neutrophil cytoplasmic antibody-associated vasculitides.Mendel A, Ennis D, Carette S, Pagnoux C Clinical and experimental rheumatology (2021)
    95. [95]
    96. [96]
      Propylthiouracil-induced otitis media with anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report and review of the literature.Hiruma M, Sasano Y, Watanabe N, Yoshihara A, Ishii S, Yaguchi Y et al. Endocrine journal (2021)
    97. [97]
      Rituximab maintenance therapy for patients with antineutrophil cytoplasmic antibody-associated vasculitis in Japan.Takeyama Y, Ono N, Shirahama Y, Inoue Y, Tanaka A, Ueda N et al. Modern rheumatology (2021)
    98. [98]
      A case of polyangiitis overlap syndrome of giant cell arteritis and granulomatosis with polyangiitis successfully treated with rituximab.Shibata A, Kondo T, Kurasawa T, Chino K, Okada Y, Amano K Modern rheumatology case reports (2021)
    99. [99]
      Vasculitis patient journey: a scoping review of patient experiences with vasculitis.Gill N, Tervaert JWC, Yacyshyn E Clinical rheumatology (2021)
    100. [100]
      Spontaneous Ecchymotic Lesions with Systemic Symptoms: A Quiz.Russo R, Cozzani E, Murdaca G, dePasquale R, Parodi A Acta dermato-venereologica (2020)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG